Vaccination with Brucella abortus recombinant In Vivo-induced antigens reduces bacterial load and promotes clearance in a mouse model for infection

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Lowry, Jake E ^a,b   Isaak, Dale D ^a   Leonhardt, Jack A ^a   Vernati, Giulia ^a   Pate, Jessie C ^a   Andrews, Gerard P ^a  

^a UNIVERSITY OF WYOMING   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; D15 PROTEIN; GAMMA INTERFERON; MALATE DEHYDROGENASE; PROTEIN AFUA; PROTEIN HIA; PROTEIN MLTA; PROTEIN VIRJ; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BRUCELLA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BRUCELLA ABORTUS; BRUCELLOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HOST RESISTANCE; IN VIVO STUDY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; GENETICS; IMMUNOLOGY; KINETICS; MICROBIOLOGY; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); BRUCELLA MELITENSIS BIOVAR ABORTUS; MURINAE; MUS;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL LOAD; BRUCELLA ABORTUS; BRUCELLA VACCINE; BRUCELLOSIS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; INTERFERON-GAMMA; KINETICS; MICE; MICE, INBRED BALB C; UP-REGULATION; VACCINATION; VACCINES, SYNTHETIC;

EID: 79952589123     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017425     Document Type: Article

References (36)

1. Schurig G, Sriranganathan N, Corbel M, (2002) Brucellosis vaccines: past, present, and future. Vet Microbiol 90: 479-496.
2. Elzer PH, Enright FM, Colby L, Hagius SD, Walker JV, et al. (1998) Protection aginst infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51. Am J Vet Res 59: 1575-1578.
3. Olsen SC, Fach SJ, Palmer MV, Sacco RE, Stoffregen WC, et al. (2006) Immune Responses of elk to initial and booster vaccinations with Brucella abortus strain RB51 or 19. Clin Vaccine Immunol 13: 1098-1103.
4. Davis, DS, Elzer, PH, (2002) Brucella vaccines in wildlife. Veterinary Microbiology 90: 533-544.
5. Cook WE, Williams ES, Thorne ET, Kreeger TJ, Stout G, et al. (2002) Brucella abortus strain RB51 vaccination in elk. I. Efficacy of reduced dosage. J Wildl Dis 38: 18-26.
6. Kreeger T, Cook W, Edwards W, Elzer P, Olsen S, (2002) Brucella abortus strain RB51 vaccination in elk. II. Failure of high dosage to prevent abortion. J Wildl Dis 38: 27-31.
7. Olsen S, Holland S, (2003) Safety of re-vaccination of pregnant bison with Brucella abortus strain RB51. J Wildl Dis 39: 824-829.
8. Olsen SC, Boyle SM, Schurig GG, Sriranganathan NN, (2009) Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus Strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes. Clin Vaccine Immunol 16: 535-540.
9. Elzer PH, Edmonds MD, Hagius SD, Walker JV, Gilsdorf MJ, et al. (1998) Safety of Brucella abortus strain RB51 in bison. J Wildl Dis 34: 825-829.
10. Olsen SC, Rhyan JC, Gidlewski T, Palmer MV, Jones AH, (1999) Biosafety and antibody response of adult bison bulls after vaccination with Brucella abortus strain RB51. Am J Vet Res 60.
11. Palmer MV, Cheville NF, Jensen AE, (1996) Experimental infection of pregnant cattle with the vaccine candidate Brucella abortus strain RB51: pathologic, bacteriologic, and serologic findings. Vet Pathol 33: 682-691.
12. Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, et al. (2001) Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun 69: 4816-4822.
13. He Y, Vemulapalli R, Schurig GG, (2002) Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type. Infect Immun 70: 2535-2543.
14. Kaushik P, Singh D, Kumar S, Tiwari A, Shukla G, et al. (2010) Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides. Veterinary Research Communications 34: 119-132.
15. Pasquevich KA, Estein SM, Samartino CG, Zwerdling A, Coria LM, et al. (2009) Immunization with recombinant Brucella Species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun 77: 436-445.
16. Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J, (2007) Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice. Vaccine 25: 6721-6729.
17. Cassataro J, Velikovsky CA, Bruno L, Estein SM, de la Barrera S, et al. (2007) Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting. Clin Vaccine Immunol 14: 869-874.
18. Ko J, Splitter GA, (2003) Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev 16: 65-78.
19. Vemulapalli R, Contreras A, Sanakkayala N, Sriranganathan N, Boyle SM, et al. (2004) Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice. Veterinary Microbiology 102: 237-245.
20. Lowry JE, Goodridge L, Vernati G, Fluegel AM, Edwards WH, et al. (2010) Identification of Brucella abortus genes in elk (Cervus elaphus) using in vivo-induced antigen technology (IVIAT) reveals novel markers of infection. Veterinary Microbiology 142: 367-372.
21. Andrews GP, Vernati G, Ulrich R, Rocke TE, Edwards WH, et al. (2010) Identification of in vivo-induced conserved sequences from Yersinia pestis during experimental plague infection in the rabbit. Vector-Borne and Zoonotic Diseases 10 (8): 749-756.
22. Spera JM, Ugalde, JE, Mucci, J, Comerci, D J, Ugalde, RA, (2006) A B-lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection. Proc Nat Acad of Sci 103: 16514-16519.
23. Montaraz JA, Winter AJ, (1986) Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect Immun 53: 245-251.
24. Cheers C, (1984) Pathogenesis and cellular immunity in experimental murine brucellosis. Dev Biol Standard 56: 237-246.
25. Bosseray N, (1992) Control methods and thresholds of acceptability for anti-Brucella vaccines. Dev Biol Standard 79: 121-128.
26. Bosseray N, Plommet M, (1990) Brucella suis S2, Brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice. Vaccine 8: 462-468.
27. Baldwin CL, Winter AJ, (1994) Macrophages and Brucella. Immunol Ser 60: 363-380.
28. Tobias L, Cordes DO, Schurig GG, (1993) Placental pathology of the pregnant mouse inoculated with Brucella abortus strain 2308. Vet Pathol 30: 119-129.
29. Tobias L, Schurig GG, Cordes DO, (1992) Comparative behaviour of Brucella abortus strains 19 and RB51 in the pregnant mouse. Res Vet Sci 53: 179-183.
30. Baldwin CL, Goenka R, (2006) Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? Crit Rev Immunology 26: 407-442.
31. Sofer-Podesta C, Ang J, Hackett NR, Senina S, Perlin D, et al. (2009) Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a Lethal Yersinia pestis challenge. Infect Immun 77: 1561-1568.
32. Alamuri P, Lower M, Hiss JA, Himpsl SD, Schneider G, et al. (2010) Adhesion,invasion, and agglutination mediated by twotrimeric autotransporters in the human uropathogen Proteus mirabilis. Infect Immun 78: 4882-4894.
33. Chirhart-Gilleland RL, Kovach ME, Elzer PH, Jennings SR, Roop RM II, (1998) Identification and characterization of a 14-kilodalton Brucella abortus protein reactive with antibodies from naturally and experimentally infected hosts and T lymphocytes from experimentally infected BALB/c mice. Infect Immun 66: 4000-4003.
34. Fernandes D, Baldwin C, (1995) Interleukin-10 downregulates protective immunity to Brucella abortus. Infect Immun 63: 1130-1133.
35. Zhong Z, Wang Y, Qiao F, Wang Z, Du X, et al. (2009) Cytotoxicity of Brucella smooth strains for macrophages is mediated by increased secretion of the type-IV secretion system. Microbiology 155: 3392-3402.
36. Wang Y, Chen Z, Qiao F, Zhong Z, Xu J, et al. (2010) The type-IV secretion system affects the expression of Omp25/Omp31 and the outer membrane properties of Brucella melitensis. FEMS Microbiology Letters 303: 92-100.